A dimeric form of a small-sized protein binder exhibits enhanced anti-tumor activity through prolonged blood circulation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A dimeric form of a small-sized protein binder exhibits enhanced anti-tumor activity through prolonged blood circulation

Published:2018-06 Issue: Volume:279 Page:282-291
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Kim Tae Yoon,Seo Hyo-Deok,Lee Joong-jae^ORCID,Kang Jung Ae,Kim Woo Sik,Kim Hye-Min,Song Ha-Yeon,Park Ji Min,Lee Dong-Eun,Kim Hak-Sung

Funder

New Drug Performance Platform Technology Development Program

Mid-Career Researcher Program

Global Research Laboratory

National Research Foundation

Ministry of Science and ICT

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference44 articles.

1. Non-immunoglobulin scaffolds: a focus on their targets;Skrlec;Trends Biotechnol.,2015

2. Engineered affinity proteins—generation and applications;Gronwall;J. Biotechnol.,2009

3. Alternative non-antibody scaffolds for molecular recognition;Skerra;Curr. Opin. Biotechnol.,2007

4. In vitro-engineered non-antibody protein therapeutics;Simeon;Protein Cell,2017

5. Display scaffolds: protein engineering for novel therapeutics;Nuttall;Curr. Opin. Pharmacol.,2008

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A bivalent form of a RBD-specific synthetic antibody effectively neutralizes SARS-CoV-2 variants;Antiviral Research;2023-12

2. Dimeric Ankyrin with Inverted Module Promotes Bifunctional Property in Capturing Capsid to Impede HIV-1 Replication;International Journal of Molecular Sciences;2023-03-09

3. Site-Specific Bioconjugation Approaches for Enhanced Delivery of Protein Therapeutics and Protein Drug Carriers;Bioconjugate Chemistry;2020-09-15

4. Site-Specific Lipidation of a Small-Sized Protein Binder Enhances the Antitumor Activity through Extended Blood Half-Life;ACS Omega;2020-07-30

5. From Synthesis to Characterization of Site-Selective PEGylated Proteins;Frontiers in Pharmacology;2019-12-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3